Clinical Trial Update: Rh-Endostatin (Endostar®) Continuous Intravenous Infusion [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for continuous intravenous infusion of Rh-Endostatin (Endostar) in lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Cancer

Drugs mentioned

• Rh-Endostatin (Endostar) (endostar (Rh-Endostatin))

Snippet

Sponsor: Affiliated Cancer Hospital & Institute of Guangzhou Medical University | Conditions: Lung Cancer | Phase 2 | Status: UNKNOWN